CP Only Training
The most common pathway for the CP-only training program is designed to provide residents with: (1) a solid foundation of knowledge in all aspects of Clinical Pathology; (2) an in-depth experience in a subspecialty of particular interest; and (3) a research experience that facilitates development of an independent physician-scientist career pathway.
The 18-month CP core curriculum (see above) is required for CP-only residents to assure familiarity with all aspects of Laboratory Medicine, while still allowing flexibility for sub-specialization within that 18 months and tailoring of CP electives to the individual interests of each resident. Research and/or clinical subspecialty opportunities are then available during the remainder of the 2nd and 3rd years of the CP-only track.
The format for the advanced training is individualized for each resident to assure both relevance to career goals and adherence to the requirements for residency training of the American Board of Pathology. Subspecialty training is handled by giving the residents more senior, graduated responsibilities under the direction of the attending physician. Some residents elect to participate in clinical fellowships in clinical pathology at this stage of their training, while others begin more basic research endeavors. Projects may be in practical areas, such as methods development or outcomes, or they may be in an area of basic research. The broad range of potential research opportunities can be explored in the Yale University medical faculty research database.
The specific research strengths of the Department of Laboratory Medicine are diverse and include R01 and program project funded investigators in immunohematology, molecular immunology and virology, transplantation immunology, molecular diagnostics, hemostasis, hematopoietic stem cells and progenitors, and clinical pharmacology, as well as other areas. The research laboratories (including the Yale Stem Cell Center) are located in close proximity to the clinical laboratories, facilitating ready interaction and transfer of biotechnology.